Literature DB >> 7074634

Chromosomes in Hodgkin's disease.

J D Rowley.   

Abstract

Chromosome studies in lymph nodes from patients with Hodgkin's disease have been limited by the low yield of dividing cells. Of 25 consecutive involved lymph nodes, 12 had no mitotic cells, three had only normal cells, seven had a mixture of normal and abnormal cells, and three had only abnormal cells. Correlating histology with the karyotype, 66% of unsuccessful samples were of the nodular sclerosing type. The majority (58%) of samples with no dividing cells were from previously treated patients. Distinct clones were obtained in samples from only four of ten patients with abnormal cells. Samples from the other six patients had single abnormal cells with bizarre marker chromosomes; these single cells probably represent the only dividing malignant cell. The high failure rate and the low number of clear-cut aneuploid clones in Hodgkin's disease contrast markedly with other lymphomas in which 80% of the samples yield mitotic cells that represent an aneuploid clone in virtually every instance.

Entities:  

Mesh:

Year:  1982        PMID: 7074634

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

1.  Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for chromosome instability.

Authors:  L Barrios; M R Caballín; R Mirò; C Fuster; G Berrozpe; A Subías; X Batlle; J Egozcue
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

2.  Numerical chromosomal aberrations in Hodgkin's disease detected by in situ hybridisation on routine paraffin sections.

Authors:  J H Pringle; J A Shaw; A Gillies; I Lauder
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

3.  DNA aneuploidy in Hodgkin's disease. A multiparameter flow-cytometric analysis with cytologic correlation.

Authors:  J Anastasi; K D Bauer; D Variakojis
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

4.  Staging laparotomy with splenectomy for Hodgkin's disease: the Stanford experience.

Authors:  M A Taylor; H S Kaplan; T S Nelsen
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

5.  [DNA content of lymphocytes and mononuclear tumor cells in Hodgkin's disease].

Authors:  K Donhuijsen; H Grethe; L D Leder
Journal:  Klin Wochenschr       Date:  1985-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.